Blood transcriptomics reveals a Parkinson's disease signature and heterogeneous prodromal molecular profiles in isolated RBD
Background: Parkinsons disease (PD) has a prolonged prodromal phase, but minimally invasive molecular biomarkers distinguishing manifest PD from prodromal synucleinopathy remain insufficiently…